Iradimed (IRMD) Profit After Tax (2013 - 2026)

Iradimed (IRMD) has 14 years of Profit After Tax data on file, last reported at $5.8 million in Q1 2026.

• On a quarterly basis, Profit After Tax rose 24.13% year-over-year to $5.8 million in Q1 2026; TTM through Mar 2026 was $23.6 million, a 19.34% increase from a year earlier, with the FY2025 full-year figure at $22.5 million, up 16.88% from the prior year.
• Profit After Tax for Q1 2026 stood at $5.8 million, down from $6.4 million in the prior quarter.
• Over the last five years, Profit After Tax for IRMD reached as high as $6.4 million in Q4 2025 and fell as low as $2.5 million in Q1 2022.
• Historically, Profit After Tax has averaged $4.6 million across 5 years, with a median of $4.7 million in 2025.
• On a YoY basis, Profit After Tax climbed as much as 120.53% in 2022 and fell as far as 5.63% in 2022.
• Year by year, Profit After Tax stood at $3.7 million in 2022, then advanced by 23.58% to $4.5 million in 2023, then gained by 13.37% to $5.1 million in 2024, then advanced by 25.17% to $6.4 million in 2025, then fell by 9.69% to $5.8 million in 2026.
• Per Business Quant data, the three most recent Profit After Tax figures were $5.8 million in Q1 2026, $6.4 million in Q4 2025, and $5.6 million in Q3 2025.